Press release
Alnylam to Host Ninth Annual “RNAi Roundtable” Webcast Series
– Series Will Culminate in a Virtual R&D Day on December 15, 2022 – CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the
About this update from Alnylam Pharmaceuticals, Inc.
[{"type":"text","content":"\n– Series Will Culminate in a Virtual R&D Day on December 15, 2022 –\n\n CAMBRIDGE, Mass.--(BUSINESS WIRE)--\nAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 9th annual series of “RNAi Roundtable” webinars over the coming weeks. The series will offer presentations from Alnylam scientists and program leaders who will review recent progress in a selection of the Company’s pipeline programs and platform innovations, as well as medical thought leaders who will provide their perspectives on clinical developments and unmet needs. Each event will be webcast live on the Investors section of the Company’s website at investors.alnylam.com/events, and a replay will be posted on the Alnylam website approximately three hours after each event.\n\nThe 2022 RNAi Roundtable schedule is as follows:\n\n\nCemdisiran, in Development for the Treatment of IgA Nephropathy (IgAN) and Other Complement-Mediated Diseases\nTuesday, September 27, 10:00 am ET\n\n\n\n\nAlnylam Engine for Sustainable Innovation: Leadership in RNAi Platform and Human Genetics\nFriday, October 21, 10:00 am ET\n\n\n\n\nCNS Delivery and ALN-APP, in Development for the Treatment of Alzheimer’s Disease and Cerebral Amyloid Angiopathy\nTuesday, November 1, 11:00 am ET\n\n\nPlease visit the Capella section of our website for the latest information regarding webcast dates.\n\nThe Company also announced today that it plans to host a virtual R&D Day event on the morning of Thursday, December 15, 2022. Alnylam management will be joined by external guest speakers for a review of the Company’s RNAi pipeline and platform activities, including advancements in its TTR franchise programs. Additional details to follow.\n\nAbout RNAi\n\nRNAi (RNA interference) is a natural cellular process of gene silencing that represents one of the most promising and rapidly advancing frontiers in biology and drug development today. Its discovery has been heralded as “a major scientific breakthrough that happens once every decade or so,” and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine. By harnessing the natural biological process of RNAi occurring in our cells, a new class of medicines known as RNAi therapeutics is now a reality. Small interfering RNA (siRNA), the molecules that mediate RNAi and c...